Lin-Lin Wang

Lin-Lin Wang

Auto-generated profile, based on publicly available information

Lin-Lin Wang

Department of Orthopaedics of Sir Run Run Shaw Hospital, and Department of Basic Medicine Sciences Zhejiang University School of Medicine Hangzhou Zhejiang China

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
SXShining Xiao
Shining Xiao
TZTengfei Zhao
Tengfei Zhao
JWJingkai Wang
Jingkai Wang
CWChenggui Wang
Chenggui Wang
JDJiangnan Du
Jiangnan Du
KXKan Xu
Kan Xu

1 January 2019 in Theranostics
Verified
Journal Article
Open access
HLHeyangzi Li
Heyangzi Li
CWChao Wang
Chao Wang
THTeng He
Teng He
TZTengfei Zhao
Tengfei Zhao
YCYingying Chen
Yingying Chen
LWLin-Lin Wang
Lin-Lin Wang
Recent studies have demonstrated that bone marrow mesenchymal stem cells (BMSCs) protect the injured neurons of spinal cord injury (SCI) from apoptosis while the underlying mechanism of the protective effect of BMSCs remains unclear. In this study, we found the transfer of mitochondria from BMSCs to injured motor neurons and detected the functional improvement after transplanting.

11 January 2022 in Frontiers in Neurology
Verified
Journal Article
Open access
LXLintao Xu
Lintao Xu
JWJingyu Wang
Jingyu Wang
YDYueming Ding
Yueming Ding
LWLinlin Wang
Linlin Wang
YZYong-Jian Zhu
Yong-Jian Zhu
Microglia are the resident immune cells in the central nervous system (CNS). After traumatic spinal cord injury (SCI), microglia undergo activation, proliferation, and changes in gene and protein expression and morphology, with detrimental and beneficial effects. Activated microglia cause secondary neuronal injuryviathe production of proinflammatory cytokines, reactive oxygen species, and proteases. However, activated microglia also promote neuronal repair through the secretion of anti-inflammatory growth factors and cytokines. Proinflammatory cytokines increase endothelial permeability, promote A1 astrocyte activation and axonal demyelination, and reduce neural stem/progenitor cells (NSPCs), leading to the exacerbation of neuronal injury. In contrast, anti-inflammatory factors facilitate angiogenesis, reduce reactive astrocytes, and promote axonal remyelination and the propagation of NSPCs, contributing to tissue repair and locomotor recovery. Due to its limited regenerative capacity, the CNS requires beneficial microglia for continuous protection against injury. Understanding and regulating microglial activation status are beneficial to reducing detrimental effects and promoting repair behaviors and to obtain more information on efficient therapies for traumatic SCI. This review discusses microglial activation and the differences between microglia and similar immune cells, microglial interactions with other cells in the spinal cord, and the progress in the development of therapies targeting microglia in SCI.

1 August 2022 in Pharmacological Research
Verified
Journal Article
Closed access
NHNing He
Ning He
GSGerong Shen
Gerong Shen
XJXiaoqin Jin
Xiaoqin Jin
HLHeyangzi Li
Heyangzi Li
JWJingyu Wang
Jingyu Wang
LWLin-Lin Wang
Lin-Lin Wang

13 April 2018 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
JWJingyu Wang
Jingyu Wang
HLHeyangzi Li
Heyangzi Li
YYYing Yao
Ying Yao
TZTengfei Zhao
Tengfei Zhao
YCYing-Ying Chen
Ying-Ying Chen
YZYongjian Zhu
Yongjian Zhu
Damage of mitochondria in the initial period of tissue injury aggravates the severity of injury. Restoration of mitochondria dysfunction and mitochondrial-based therapeutics represent a potentially effective therapeutic strategy. Recently, mitochondrial transfer from stem cells has been demonstrated to play a significant role in rescuing injured tissues. The possible mechanisms of mitochondria released from stem cells, the pathways of mitochondria transfer between the donor stem cells and recipient cells, and the internalization of mitochondria into recipient cells are discussed. Moreover, a novel strategy for tissue injury based on the concept of stem cell-derived mitochondrial transplantation is pointed out, and the advantages and challenges are summarized.

26 November 2020 in Frontiers in Medicine
Verified
Journal Article
Open access
XMXingjia Mao
Xingjia Mao
PFPanfeng Fu
Panfeng Fu
LWLinlin Wang
Linlin Wang
CXchuan Xiang
chuan Xiang
Osteoarthritis (OA) is a common and disabling joint disorder that is mainly characterized by cartilage degeneration and narrow joint spaces. The role of mitochondrial dysfunction in promoting the development of OA has gained much attention. Targeting endogenous molecules to improve mitochondrial function is a potential treatment for OA. Moreover, research on exogenous drugs to improve mitochondrial function in OA based on endogenous molecular targets has been accomplished. In addition, stem cells and exosomes have been deeply researched in the context of cartilage regeneration, and these factors both reverse mitochondrial dysfunctions. Thus, we hypothesize that biomedical approaches will be applied to the treatment of OA. Furthermore, we have summarized the global status of mitochondria and osteoarthritis research in the past two decades, which will contribute to the research field and the development of novel treatment strategies for OA.